Electra City Tower
58 Harakevet St.
Tel Aviv
6777016
Ken Shaked
Ken has over 20 years’ experience in providing ongoing legal services to corporates and commercial entities.
Thanks to his many years of activity in business development, management of startup companies, and investment in corporations, Ken supports entrepreneurs and startups from the project launch phase through to the exit phase.
In the course of this activity, Ken advises on issues related to setting up companies and raising funds for their activities. He also counsels on ongoing commercial issues, including licensing and intellectual property, distribution and cooperation agreements, research and development agreements, regulation, and so forth. Ken’s clients operate in a range of high-tech fields, with an emphasis on pharma, biotechnology, medical equipment, and cleantech.
Ken has served as in-house counsel for leading companies, including El-Al and Dexcel Pharma. He has also worked and served as a partner for a number of leading law firms.
Prominent legal directory The Legal 500 ranks Ken as a Recommended Lawyer in Commercial, Corporate and M&A, Hi-Tech and Start-Ups, Intellectual property: Commercial/ Transactions
In addition, Ken managed various startups in the course of his role as vice president of Yissum Research Development Company of the Hebrew University, as well as CEO of various companies in the areas of cleantech, biotechnology, and medical equipment.
Education:
Tel Aviv University LL.B., 1991
Haifa University MBA, 2004
Admission:
Member of Israel Bar Association since 1991
Insights & News - Ken Shaked:
Barnea: Representing QDM in Transaction with Israel Electric Corporation
Ken Shaked and Nir Alter represented the startup company QDM (Quantum Design Materials) in a transaction with the Israel Electric Corporation (IEC). As part of the transaction, the IEC invested USD 1.1 million in QDM, which develops room-temperature superconductors. In addition, QDM and the IEC signed a cooperation agreement allowing the IEC to conduct a pilot to examine the applicability and suitability of QDM’s innovative technology for its needs.